AMGN
46
2
KEY
27
3
ORLY
52
5
KIM
60
3
EA
44
3
PRU
47
2
TEL
60
2
FITB
35
2
HCA
39
2
AMG
52
3
BXP
41
3
RSG
56
2
DHI
29
2
IPG
42
2
AMT
33
3
WEC
41
2
DOW
47
3
DHR
40
5
NRG
39
4
PVH
62
4
AMGN
46
2
KEY
27
3
ORLY
52
5
KIM
60
3
EA
44
3
PRU
47
2
TEL
60
2
FITB
35
2
HCA
39
2
AMG
52
3
BXP
41
3
RSG
56
2
DHI
29
2
IPG
42
2
AMT
33
3
WEC
41
2
DOW
47
3
DHR
40
5
NRG
39
4
PVH
62
4
Financhill
Back

Virtus Investment Partners Vs. Verona Pharma PLC Industry Stock Comparison

Buy
57

VRTS
Virtus Investment Partners

Last Price:
$222.64
Seasonality Move:
2.04%
Sell
48

VRNA
Verona Pharma PLC

Last Price:
$45.02
Seasonality Move:
1.28%
Buy
57
Virtus Investment Partners (VRTS) is a Buy

Is Virtus Investment Partners a Buy, Sell or Hold?

  • The current Virtus Investment Partners [VRTS] share price is $223.50. The Score for VRTS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • VRTS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC a Buy, Sell or Hold?

  • The current Verona Pharma PLC [VRNA] share price is $45.04. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTS Stock Price Chart

What is Virtus Investment Partners's stock price today?

  • The Virtus Investment Partners share price today is $223.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTS is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRNA Stock Price Chart

What is Verona Pharma PLC's stock price today?

  • The Verona Pharma PLC share price today is $45.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing slight selling pressure.

VRTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.59 Sell
Relative Strength Index (14 RSI): 37.99 Sell
Chaikin Money Flow: 14165 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (228.57 - 248.85) Sell
Bollinger Bands (100): (201.55 - 235.11) Buy

VRNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.65 Buy
Relative Strength Index (14 RSI): 68.18 Buy
Chaikin Money Flow: -67723 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.54 - 42.18) Buy
Bollinger Bands (100): (26.89 - 38.85) Buy

VRTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 226.87 Sell
20-day SMA: 238.77 Sell
50-day SMA: 232.11 Sell
200-day SMA: 224.37 Sell
8-day EMA: 226.7 Sell
20-day EMA: 233.04 Sell
50-day EMA: 230.9 Sell
200-day EMA: 222.85 Buy

VRNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.43 Buy
20-day SMA: 40.79 Buy
50-day SMA: 38.03 Buy
200-day SMA: 24.5 Buy
8-day EMA: 42.68 Buy
20-day EMA: 40.99 Buy
50-day EMA: 37.9 Buy
200-day EMA: 27.99 Buy

Virtus Investment Partners Earnings Growth & VRTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.66 per share, and an increase next year of $3.49 per share.

Verona Pharma PLC Earnings Growth & VRNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.

Virtus Investment Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):